{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:34:00Z","timestamp":1790645640942,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-06288-y","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:17:58Z","timestamp":1762255078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical analysis of Pneumocystis jirovecii pneumonia in children with malignant disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Haiyan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mincui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaotian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxiu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"3","key":"6288_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/s0022-3476(73)80113-1","volume":"82","author":"WT Hughes","year":"1973","unstructured":"Hughes WT, Price RA, Kim HK, et al. Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr. 1973;82(3):404\u201315. https:\/\/doi.org\/10.1016\/s0022-3476(73)80113-1.","journal-title":"J Pediatr"},{"issue":"1","key":"6288_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijid.2008.03.027","volume":"13","author":"S Viboon Boonsarngsuk","year":"2009","unstructured":"Viboon Boonsarngsuk S, Sirilak S, Kiatboonsri. Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors.International journal of infectious diseases: IJID. : Official Publication Int Soc Infect Dis. 2009;13(1):59\u201366. https:\/\/doi.org\/10.1016\/j.ijid.2008.03.027.","journal-title":": Official Publication Int Soc Infect Dis"},{"key":"6288_CR3","doi-asserted-by":"publisher","unstructured":"Romain L\u00e9cuyer Nah\u00e9ma, Issa F, Camou et al. Characteristics and prognosis factors of Pneumocystis jirovecii pneumonia according to underlying disease: A retrospective multicenter Study.Chest 2024;165(6):1319\u201329 https:\/\/doi.org\/10.1016\/j.chest.2024.01.015","DOI":"10.1016\/j.chest.2024.01.015"},{"key":"6288_CR4","doi-asserted-by":"publisher","unstructured":"Shane J, Cross J, Wolf PA, Patel. Prevention, Diagnosis and Management of Pneumocystis jirovecii Infection in Children With Cancer or Receiving Hematopoietic Cell Therapy.The Pediatric infectious disease journal 2023 12 01;42(12):e479-e482 https:\/\/doi.org\/10.1097\/INF.0000000000004102","DOI":"10.1097\/INF.0000000000004102"},{"key":"6288_CR5","doi-asserted-by":"publisher","unstructured":"Romain L\u00e9cuyer N, Issa B, Tessoulin et al. Epidemiology and clinical impact of respiratory coinfections at diagnosis of Pneumocystis jirovecii pneumonia. J Infect Dis 2022 03 02;225(5):868\u201380 https:\/\/doi.org\/10.1093\/infdis\/jiab460","DOI":"10.1093\/infdis\/jiab460"},{"key":"6288_CR6","doi-asserted-by":"publisher","unstructured":"Anat Stern H, Green M. Paul, Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.The Cochrane database of systematic reviews 2014;(10):CD005590 https:\/\/doi.org\/10.1002\/14651858.CD005590.pub3","DOI":"10.1002\/14651858.CD005590.pub3"},{"key":"6288_CR7","doi-asserted-by":"publisher","unstructured":"Paul A, Trubin, Marwan M, Azar. Current concepts in the diagnosis and management of Pneumocystis pneumonia in solid organ Transplantation.Infectious disease clinics of. North Am 2023 09;37(3):617\u201340 https:\/\/doi.org\/10.1016\/j.idc.2023.03.005","DOI":"10.1016\/j.idc.2023.03.005"},{"key":"6288_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00224","volume":"10","author":"A Dunbar","year":"2020","unstructured":"Dunbar A, Schauwvlieghe A, Algoe S, et al. Epidemiology of Pneumocystis jirovecii pneumonia and (Non-)use of prophylaxis. Front Cell Infect Microbiol. 2020;10:224. https:\/\/doi.org\/10.3389\/fcimb.2020.00224.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"6288_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jof8111167","volume":"8","author":"A Apostolopoulou","year":"2022","unstructured":"Apostolopoulou A, Fishman JA. The pathogenesis and diagnosis of Pneumocystis jiroveci pneumonia. J Fungi. 2022;8(11):1167. https:\/\/doi.org\/10.3390\/jof8111167.","journal-title":"J Fungi"},{"issue":"4","key":"6288_CR10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1378\/chest.07-0223","volume":"132","author":"C Guillaume Boll\u00e9e","year":"2007","unstructured":"Guillaume Boll\u00e9e C, Sarfati G, Thi\u00e9ry, et al. Clinical picture of Pneumocystis Jiroveci pneumonia in cancer. Patients Chest. 2007;132(4):1305\u201310. https:\/\/doi.org\/10.1378\/chest.07-0223.","journal-title":"Patients Chest"},{"key":"6288_CR11","doi-asserted-by":"publisher","unstructured":"Maschmeyer G, Helweg-Larsen J, Pagano L, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother. 2016(9). https:\/\/doi.org\/10.1093\/jac\/dkw158.","DOI":"10.1093\/jac\/dkw158"},{"key":"6288_CR12","doi-asserted-by":"publisher","unstructured":"Emilie Fr\u00e9alle S, Valade N, Guigue et al. Diffusion of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis colonization: frequency and putative risk factors.Medical mycology 2017;55(5):568\u201372 https:\/\/doi.org\/10.1093\/mmy\/myw113","DOI":"10.1093\/mmy\/myw113"},{"key":"6288_CR13","doi-asserted-by":"publisher","unstructured":"Annika Y, Classen L, Henze M, von Lilienfeld-Toal et al. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the infectious Diseases.Working party of the German society of hematology and medical oncology (AGIHO\/DGHO)Annals of hematology 2021;100(6):1603\u201320 https:\/\/doi.org\/10.1007\/s00277-021-04452-9","DOI":"10.1007\/s00277-021-04452-9"},{"issue":"1","key":"6288_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1186\/s12885-021-08727-2","volume":"21","author":"S Koichi Takeda","year":"2021","unstructured":"Koichi Takeda S, Harada B, Hayama, et al. Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large cancer center. BMC Cancer. 2021;21(1):987. https:\/\/doi.org\/10.1186\/s12885-021-08727-2.","journal-title":"BMC Cancer"},{"issue":"2","key":"6288_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jpeds.2013.10.021","volume":"164","author":"MG D\u00e9sir\u00e9e Caselli","year":"2014","unstructured":"D\u00e9sir\u00e9e Caselli MG, Petris R, Rondelli, et al. Single-day trimethoprim\/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer. J Pediatr. 2014;164(2):389\u2013e921. https:\/\/doi.org\/10.1016\/j.jpeds.2013.10.021.","journal-title":"J Pediatr"},{"key":"6288_CR16","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","volume":"71","author":"J Maertens","year":"2016","unstructured":"Maertens J, Cesaro S, Maschmeyer G, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2397\u2013404. https:\/\/doi.org\/10.1093\/jac\/dkw157.","journal-title":"J Antimicrob Chemother"},{"key":"6288_CR17","doi-asserted-by":"publisher","unstructured":"Anat Stern H, Green M, Paul et al. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.The Cochrane database of systematic reviews 2014;(10):CD005590 https:\/\/doi.org\/10.1002\/14651858.CD005590.pub3","DOI":"10.1002\/14651858.CD005590.pub3"},{"issue":"2","key":"6288_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5863\/1551-6776-28.2.123","volume":"28","author":"K Justin","year":"2023","unstructured":"Justin K, Chen J, Guerci H, Corbo, et al. Low-Dose TMP-SMX for Pneumocystis jirovecii pneumonia prophylaxis in pediatric solid organ transplant Recipients.The journal of pediatric Pharmacology and therapeutics: JPPT. Official J PPAG. 2023;28(2):123\u20138. https:\/\/doi.org\/10.5863\/1551-6776-28.2.123.","journal-title":"Official J PPAG"},{"issue":"26","key":"6288_CR19","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","volume":"316","author":"WT Hughes","year":"1987","unstructured":"Hughes WT, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1987;316(26):1627\u201332. https:\/\/doi.org\/10.1056\/NEJM198706253162604.","journal-title":"N Engl J Med"},{"issue":"8","key":"6288_CR20","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1177\/1078155220979046","volume":"27","author":"CM Monica Awad","year":"2021","unstructured":"Monica Awad CM, Sierra E, Mesghali, et al. Twice weekly prophylaxis with trimethoprim\/sulfamethoxazole for Pneumocystis jirovecii pneumonia in pediatric oncology patients. J Oncol Pharm Practice: Official Publication Int Soc Oncol Pharm Practitioners. 2021;27(8):1936\u20139. https:\/\/doi.org\/10.1177\/1078155220979046.","journal-title":"J Oncol Pharm Practice: Official Publication Int Soc Oncol Pharm Practitioners"},{"issue":"1","key":"6288_CR21","doi-asserted-by":"publisher","first-page":"e13231","DOI":"10.1111\/tid.13231","volume":"22","author":"A Elio Castagnola","year":"2020","unstructured":"Elio Castagnola A, Mesini C, Saffioti, et al. Failures of once-a-week trimethoprim-sulfamethoxazole prophylaxis in children undergoing allogeneic hematopoietic stem cell transplant.Transplant infectious disease: an. Official J Transplantation Soc. 2020;22(1):e13231. https:\/\/doi.org\/10.1111\/tid.13231.","journal-title":"Official J Transplantation Soc"},{"key":"6288_CR22","doi-asserted-by":"publisher","unstructured":"Mansell PW. Acquired immune deficiency syndrome, leading to opportunistic infections, Kaposi\u2019s sarcoma, and other malignancies.Critical reviews in clinical laboratory sciences 1984;20(3):191\u2013204 https:\/\/doi.org\/10.3109\/10408368409165774","DOI":"10.3109\/10408368409165774"},{"key":"6288_CR23","first-page":"141","volume":"43","author":"GW Geelhoed","year":"1976","unstructured":"Geelhoed GW. Open lung biopsy in the diagnosis of Pneumocystis carinii pneumonia. Natl Cancer Inst Monogr. 1976;43:141\u20137.","journal-title":"Natl Cancer Inst Monogr"},{"key":"6288_CR24","doi-asserted-by":"publisher","unstructured":"Rego de Figueiredo I, Vieira Alves R, Drummond Borges D et al. Pneumocystosis pneumonia: A comparison study between HIV and non-HIV immunocompromised patients.Pulmonology 2019. Sep - Oct;25(5):271\u20134 https:\/\/doi.org\/10.1016\/j.pulmoe.2019.04.003","DOI":"10.1016\/j.pulmoe.2019.04.003"},{"key":"6288_CR25","doi-asserted-by":"publisher","unstructured":"Ashley V, Geerlinks A, Campigotto M, Science et al. Impact of prophylaxis choice on risk of Pneumocystis pneumonia in children with cancer: A case-control study.European journal of cancer (Oxford, england: 1990) 2020 11;140:71\u20135 https:\/\/doi.org\/10.1016\/j.ejca.2020.09.013","DOI":"10.1016\/j.ejca.2020.09.013"},{"key":"6288_CR26","doi-asserted-by":"publisher","unstructured":"Erica Ricci C, Bartalucci C, Russo, et al. Clinical and radiological features of Pneumocystis jirovecii pneumonia in children: A case Series.Journal of fungi (Basel. Switzerland). 2024;10(4). https:\/\/doi.org\/10.3390\/jof10040276.","DOI":"10.3390\/jof10040276"},{"key":"6288_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652383","volume":"12","author":"G Tang","year":"2021","unstructured":"Tang G, Tong S, Yuan X, et al. Using routine laboratory markers and immunological indicators for predicting Pneumocystis jiroveci pneumonia in immunocompromised patients. Front Immunol. 2021;12:652383. https:\/\/doi.org\/10.3389\/fimmu.2021.652383.","journal-title":"Front Immunol"},{"key":"6288_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.phrs.2018.06.010","volume":"134","author":"S Brakemeier","year":"2018","unstructured":"Brakemeier S, et al. Prophylaxis and treatment of Pneumocystis jirovecii pneumonia after solid organ transplantation. Pharmacol Res. 2018;134:61\u20137.","journal-title":"Pharmacol Res"},{"key":"6288_CR29","doi-asserted-by":"publisher","unstructured":"Anke Barnbrock A, M\u00f6ricke D, Barbaric et al. Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009.British journal of haematology 2024;204(6):2319\u201323 https:\/\/doi.org\/10.1111\/bjh.19382","DOI":"10.1111\/bjh.19382"},{"issue":"1","key":"6288_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-02300-8","volume":"23","author":"L Huang","year":"2023","unstructured":"Huang L, Xu S, Huang Z, et al. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing. BMC Pulm Med. 2023;23(1):72. https:\/\/doi.org\/10.1186\/s12890-022-02300-8.","journal-title":"BMC Pulm Med"},{"key":"6288_CR31","doi-asserted-by":"publisher","unstructured":"Ariel D, Szvalb AE, Malek Y, Jiang et al. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR.The journal of infection 2020 09;81(3):443\u201351 https:\/\/doi.org\/10.1016\/j.jinf.2020.07.003","DOI":"10.1016\/j.jinf.2020.07.003"},{"issue":"1","key":"6288_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03135-1","volume":"24","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Liu T, Ming M, et al. Metagenomic next-generation sequencing promotes diagnosis and treatment of Pneumocystis jirovecii pneumonia in non-HIV infected children: a retrospective study. BMC Pulm Med. 2024;24(1):338. https:\/\/doi.org\/10.1186\/s12890-024-03135-1.","journal-title":"BMC Pulm Med"},{"key":"6288_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/IDR.S444571","volume":"17","author":"M-Q Huang","year":"2024","unstructured":"Huang M-Q, Zheng T-T, Wang X-R, et al. The clinical value of metagenomic Next-Generation sequencing in Pneumocystis jirovecii pneumonia. Infect Drug Resist. 2024;17:69\u201380. https:\/\/doi.org\/10.2147\/IDR.S444571.","journal-title":"Infect Drug Resist"},{"key":"6288_CR34","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2147\/IDR.S450878","volume":"17","author":"S Li","year":"2024","unstructured":"Li S, Han X, Ma J, et al. Study on mNGS technique in diagnosing Pneumocystis jirovecii pneumonia in Non-HIV-Infected patients. Infect Drug Resist. 2024;17:1397\u2013405. https:\/\/doi.org\/10.2147\/IDR.S450878.","journal-title":"Infect Drug Resist"},{"key":"6288_CR35","doi-asserted-by":"publisher","unstructured":"Sejal Morjaria J, Frame A, Franco-Garcia et al. Clinical performance of (1,3) Beta-D glucan for the diagnosis of Pneumocystis pneumonia (PCP) in cancer patients tested with PCP polymerase chain Reaction.Clinical infectious diseases: an official publication of the infectious diseases society of America 2019 09 27;69(8):1303\u20139 https:\/\/doi.org\/10.1093\/cid\/ciy1072","DOI":"10.1093\/cid\/ciy1072"},{"key":"6288_CR36","doi-asserted-by":"publisher","unstructured":"Li Liu M, Yuan Y, Shi et al. Clinical performance of BAL metagenomic Next-Generation sequence and serum (1,3)-\u03b2-D-Glucan for differential diagnosis of Pneumocystis jirovecii pneumonia and Pneumocystis jirovecii Colonisation.Frontiers in cellular and infection microbiology 2021;11:784236 https:\/\/doi.org\/10.3389\/fcimb.2021.784236","DOI":"10.3389\/fcimb.2021.784236"},{"key":"6288_CR37","doi-asserted-by":"publisher","unstructured":"Yang Liu X, Wang J, Xu et al. Diagnostic value of metagenomic next-generation sequencing of lower respiratory tract specimen for the diagnosis of suspected Pneumocystis jirovecii pneumonia.Annals of medicine 2023 12;55(1):2232358 https:\/\/doi.org\/10.1080\/07853890.2023.2232358","DOI":"10.1080\/07853890.2023.2232358"},{"issue":"1","key":"6288_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04608-1","volume":"27","author":"DR Giacobbe","year":"2023","unstructured":"Giacobbe DR, Dettori S, Di Pilato V, et al. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG. Crit Care. 2023;27(1):323. https:\/\/doi.org\/10.1186\/s13054-023-04608-1.","journal-title":"Crit Care"},{"key":"6288_CR39","doi-asserted-by":"publisher","unstructured":"Corpo BM-KOD, Gingras M-A et al. Development of a clinical risk score for the prediction of Pneumocystis jirovecii pneumonia in hospitalised patients.BMC infectious diseases 2024;24(1):1032 https:\/\/doi.org\/10.1186\/s12879-024-09957-y","DOI":"10.1186\/s12879-024-09957-y"},{"key":"6288_CR40","doi-asserted-by":"publisher","unstructured":"Butler-Laporte ODCG, Donald C, Sheppard, Diseases et al. 2020;26(9):1137\u201343 https:\/\/doi.org\/10.1016\/j.cmi.2020.05.024","DOI":"10.1016\/j.cmi.2020.05.024"},{"key":"6288_CR41","doi-asserted-by":"publisher","unstructured":"Jumpei Taniguchi K, Nakashima H, Matsui et al. Low cut-off value of serum (1,3)-beta-D-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study.BMC infectious diseases. 2021;21(1):1200 https:\/\/doi.org\/10.1186\/s12879-021-06895-x","DOI":"10.1186\/s12879-021-06895-x"},{"issue":"1","key":"6288_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-023-00650-7","volume":"22","author":"Y Huang","year":"2023","unstructured":"Huang Y, Yi J, Song J-J, et al. Negative serum (1,3) -\u03b2-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR. Ann Clin Microbiol Antimicrob. 2023;22(1):102. https:\/\/doi.org\/10.1186\/s12941-023-00650-7.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"6288_CR43","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.2147\/IDR.S459722","volume":"17","author":"W Luo","year":"2024","unstructured":"Luo W, Lin X, Chen Y, et al. Metagenomic Next-Generation sequencing for accurate diagnosis of Pneumocystis jirovecii pneumonia: A comparative study with traditional. MethodsInfection Drug Resist. 2024;17:2965\u201374. https:\/\/doi.org\/10.2147\/IDR.S459722.","journal-title":"MethodsInfection Drug Resist"},{"key":"6288_CR44","doi-asserted-by":"publisher","unstructured":"Jay A, Fishman H, Gans, AST Infectious Diseases Community of Practice. ; Pneumocystis Jiroveci in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of Practice.Clinical transplantation 2019 09;33(9):e13587 https:\/\/doi.org\/10.1111\/ctr.13587","DOI":"10.1111\/ctr.13587"},{"key":"6288_CR45","doi-asserted-by":"publisher","unstructured":"Hui Qi D, Dong N, Liu et al. Efficacy of initial Caspofungin plus trimethoprim\/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection.BMC infectious diseases 2023;23(1):409 https:\/\/doi.org\/10.1186\/s12879-023-08372-z","DOI":"10.1186\/s12879-023-08372-z"},{"issue":"3","key":"6288_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/1120009X.2022.2095155","volume":"35","author":"J Guo","year":"2023","unstructured":"Guo J, Chen Z, Kong C, et al. Meta-analysis of echinocandins combined with trimethoprim-sulfamethoxazole for treatment of Pneumocystis pneumonia. J Chemother. 2023;35(3):181\u20137. https:\/\/doi.org\/10.1080\/1120009X.2022.2095155.","journal-title":"J Chemother"},{"key":"6288_CR47","doi-asserted-by":"publisher","unstructured":"Lin Ding H, Huang H, Wang et al. Adjunctive corticosteroids May be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies.Annals of intensive care 2020;10(1):34 https:\/\/doi.org\/10.1186\/s13613-020-00649-9","DOI":"10.1186\/s13613-020-00649-9"},{"issue":"1","key":"6288_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10151-3","volume":"24","author":"Y Morimoto","year":"2024","unstructured":"Morimoto Y, Matsui H, Fujioka H, et al. Effectiveness of pulse methylprednisolone in patients with non-human immunodeficiency virus pneumocystis pneumonia: a multicentre, retrospective registry-based cohort study. BMC Infect Dis. 2024;24(1):1233. https:\/\/doi.org\/10.1186\/s12879-024-10151-3.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6288_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09031-7","volume":"24","author":"H Li","year":"2024","unstructured":"Li H, Lu Y, Tian G, et al. A regimen based on the combination of trimethoprim\/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related Pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital. BMC Infect Dis. 2024;24(1):152. https:\/\/doi.org\/10.1186\/s12879-024-09031-7.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"6288_CR50","doi-asserted-by":"publisher","first-page":"e0250611","DOI":"10.1371\/journal.pone.0250611","volume":"16","author":"J\u00e9r\u00f4me Mehdi Assal","year":"2021","unstructured":"Mehdi Assal J\u00e9r\u00f4me, Lambert L, Chow-Chine, et al. Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: A propensity score analysis. PLoS ONE. 2021;16(4):e0250611. https:\/\/doi.org\/10.1371\/journal.pone.0250611.","journal-title":"PLoS ONE"},{"issue":"4","key":"6288_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3949\/ccjm.91a.23082","volume":"91","author":"Simran Gupta","year":"2024","unstructured":"Gupta Simran, Bebell Lisa M. When should i give corticosteroids to my patient with Pneumocystis pneumonia? Cleve Clin J Med. 2024;91(4):217\u20139. https:\/\/doi.org\/10.3949\/ccjm.91a.23082.","journal-title":"Cleve Clin J Med"},{"key":"6288_CR52","doi-asserted-by":"publisher","unstructured":"Alexandre Alanio, Philippe M, Hauser K, Lagrou et al. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.The Journal of antimicrobial chemotherapy. 2016 09;71(9):2386-96 https:\/\/doi.org\/10.1093\/jac\/dkw156","DOI":"10.1093\/jac\/dkw156"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06288-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06288-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06288-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:28:59Z","timestamp":1762295339000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-06288-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6288"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06288-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of Hunan Children\u2019s Hospital under number KYSQ2021-, and written informed consent was waived due to the anonymized retrospective nature of the analysis. All methods were performed in accordance with relevant guidelines and regulations.Our study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"906"}}